$0.00 $0.00 (260.0%)

03:40 PM EDT on 07/16/19

Epirus Biopharmaceuticals Inc Com (NASDAQOTH:EPRSQ)

CAPS Rating: No stars

A biopharmaceutical company pioneering the new field of synergistic combination pharmaceuticals, with a portfolio of product candidates in phase 2 clinical development.

Current Price $0.00 Mkt Cap $34,040.00
Open $0.00 P/E Ratio 0.00
Prev. Close $0.00 Div. (Yield) $0.00 (0.0%)
Daily Range $0.00 - $0.00 Volume 10,000
52-Wk Range $0.00 - $0.01 Avg. Daily Vol. 1

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

246 Outperform
14 Underperform
 

All-Star Players

20 Outperform
3 Underperform
 

Wall Street

9 Outperform
0 Underperform
 

Top NASDAQOTH:EPRSQ Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

jfogarty25 (< 20)
Submitted November 27, 2013

Chronic Pain meds that are not narcotics have HUGE potential. If this Z944 ever catches fire and works this could be a 10 bagger. Could also fail completely like Z160. Seems like they have enough other pipe line potential to warrant expectation of a… More

thecyberguy (77.44)
Submitted June 05, 2008

Who??

NASDAQOTH:EPRSQ VS S&P 500 (SPY)

Fools bullish on NASDAQOTH:EPRSQ are also bullish on:

Fools bearish on NASDAQOTH:EPRSQ are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about EPRSQ.

Recs

1
Member Avatar jfogarty25 (< 20) Submitted: 11/26/2013 8:37:28 PM : Outperform Start Price: $13.00 NASDAQ OTHER:EPRSQ Score: -165.20

Chronic Pain meds that are not narcotics have HUGE potential. If this Z944 ever catches fire and works this could be a 10 bagger. Could also fail completely like Z160. Seems like they have enough other pipe line potential to warrant expectation of a low downside and large upside potential.

Recs

0
Member Avatar Sn8keiis (< 20) Submitted: 1/2/2013 8:29:03 AM : Outperform Start Price: $39.60 NASDAQ OTHER:EPRSQ Score: -205.93

Bargain price for a stock with HUGE potential. 1000 shares for less than a $1000 mitigates risk.

Recs

0
Member Avatar acumulator (< 20) Submitted: 8/20/2012 7:46:10 PM : Outperform Start Price: $75.60 NASDAQ OTHER:EPRSQ Score: -209.64

The potential for good news on there pain drug Synavive, could move the price of this stock up in the next several months which could make this a good trade.

Leaderboard

Find the members with the highest scoring picks in EPRSQ.

Score Leader

longtermgrowth09

longtermgrowth09 (26.75) Score: +265.67

The Score Leader is the player with the highest score across all their picks in EPRSQ.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
longtermgrowth09 26.75 8/3/2010 Underperform 5Y $94.80 -100.00% +165.67% +265.67 0 Comment
salesgenieshort < 20 4/14/2010 Underperform 5Y $90.00 -100.00% +148.47% +248.46 0 Comment
spolack 80.33 4/1/2008 Underperform NS $194.40 -100.00% +128.61% +228.61 0 Comment
dozer963 24.89 4/8/2008 Underperform NS $195.60 -100.00% +127.47% +227.47 0 Comment
FUZZYMINKINS < 20 7/11/2011 Underperform 5Y $163.80 -100.00% +125.11% +225.11 0 Comment
cchigga 88.67 6/11/2012 Underperform 5Y $81.00 -100.00% +125.12% +225.11 0 Comment
williamgcash < 20 7/6/2011 Underperform 3Y $155.70 -100.00% +123.08% +223.08 0 Comment
thecyberguy 77.44 6/5/2008 Underperform 1Y $231.00 -100.00% +121.81% +221.81 2 Comments
uncletupelo61 < 20 12/4/2012 Underperform 3M $39.00 -100.00% +111.28% +211.27 0 Comment
raisethesky < 20 9/18/2007 Underperform NS $360.00 -100.00% +110.85% +210.85 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackMLVCo < 20 12/21/2011 Outperform NS $73.80 -13.82% +11.41% -25.23 4/17/2012 @ $63.60 0 Comment
TrackUltraLong < 20 11/4/2011 Outperform NS $73.20 -100.00% +138.62% -238.62 1 Comment
TrackCanaccord 63.75 9/12/2011 Outperform NS $77.40 -100.00% +161.06% -261.05 0 Comment
TrackOppenheimer 20.08 7/5/2011 Outperform NS $151.20 -100.00% +123.37% -223.37 0 Comment
TrackWedbush 88.35 4/20/2011 Outperform NS $177.00 -100.00% +124.65% -224.65 0 Comment
TrackJMP 84.18 3/25/2011 Outperform NS $132.60 -100.00% +127.16% -227.16 0 Comment
TrackZacks < 20 9/13/2010 Outperform 3M $80.40 -64.18% +22.57% -86.75 11/9/2012 @ $28.80 1 Comment
TrackJGreenblatt 46.10 6/15/2010 Outperform 1Y $85.20 +49.30% +15.69% +33.60 6/20/2011 @ $127.20 1 Comment
TrackLadenburg < 20 7/28/2008 Outperform NS $234.00 -79.48% -15.81% -63.67 10/6/2008 @ $48.01 0 Comment
TrackPZK < 20 2/19/2008 Outperform NS $318.00 -80.00% +1.23% -81.23 4/17/2012 @ $63.60 0 Comment
TrackPiperJaff 86.17 1/3/2008 Outperform NS $300.00 -100.00% +114.91% -214.91 0 Comment
TrackEveillard 93.75 9/30/2007 Outperform NS $375.00 -100.00% +105.20% -205.20 2 Comments
TrackLazardCapit 49.77 1/23/2007 Outperform NS $494.40 -100.00% +122.96% -222.96 0 Comment
TrackRodmanRen < 20 1/5/2007 Outperform NS $489.00 -100.00% +124.42% -224.42 0 Comment

Advertisement